FORA Capital’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
Other funds holding TERN
FORA Capital's TERN Position: Q2 2026 in Review
FORA Capital sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 27,120 shares — an estimated $1.43M sold.
FORA Capital first reported a position in TERN in Q4 2025 and held it in 2 quarters. The position peaked at $1.43M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.
- FORA Capital reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- FORA Capital sold 27,120 Terns Pharmaceuticals shares in Q2 2026, an estimated $1.43M.
- FORA Capital first reported a position in Terns Pharmaceuticals in Q4 2025 and held it in 2 quarters.
- FORA Capital's Terns Pharmaceuticals position peaked at $1.43M in Q1 2026.
- 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.
Based on FORA Capital's 13F filing for Q2 2026, filed 13 Aug 2026.